rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 
Rediff.com  » Sports » Evans says never discussed doping with Armstrong doctor

Evans says never discussed doping with Armstrong doctor

October 22, 2012 14:21 IST

Australia's 2011 Tour De France winner Cadel Evans has admitted meeting the Italian doctor at the heart of the Lance Armstrong scandal more than a decade ago but said they never discussed doping.

Evans, who was Australia's first winner of the endurance classic, said in an e-mail to Australia's SBS television that he met with Michele Ferrari to undergo a test to ascertain his suitability for road racing.

Cadel EvansFerrari was banned from involvement in cycling for life after the publication of the US Anti-Doping Agency (USADA)'s report alleging that Armstrong won his record seven Tour titles on the back of a highly sophisticated doping regime.

"My only motive at the time ... was to understand my capabilities as a road rider," Evans wrote.

"At that time, Mr Ferrari's opinion was very highly regarded by teams and team managers, and therefore helpful for me to gain opportunities with road teams.

"There was never any discussion of doping (with Dr Ferrari) or any sign of anything illegal.

"I have never seen or had contact before or after this test."

Cycling's governing body UCI will announce later on Monday whether it has ratified the USADA's sanctions, including stripping Armstrong of his Tour titles.

Photograph: Doug Pensinger/Getty Images

Also Read

 How the noose was tied around Armstrong's neck

- All about the Lance Armstrong doping case

- Factbox: State of the Lance Armstrong Foundation's finances

- Armstrong steps down from charity; Nike drops sponsorship

- We will move forward: Lance Armstrong

- Armstrong could take lie test over doping

Source:
© Copyright 2014 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.